Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
BMC Infect Dis ; 20(1): 669, 2020 Sep 14.
Artículo en Inglés | MEDLINE | ID: mdl-32928130

RESUMEN

BACKGROUND: The parasite Entamoeba histolytica is the causal agent of amoebiasis, a worldwide emerging disease. Amebic brain abscess is a form of invasive amebiasis that is both rare and frequently lethal. This condition always begins with the infection of the colon by E. histolytica trophozoites, which subsequently travel through the bloodstream to extraintestinal tissues. CASE PRESENTATION: We report a case of a 71-year-old female who reported an altered state of consciousness, disorientation, sleepiness and memory loss. She had no history of hepatic or intestinal amoebiasis. A preliminary diagnosis of colloidal vesicular phase neurocysticercosis was made based on nuclear magnetic resonance imaging (NMRI). A postsurgery immunofluorescence study was positive for the 140 kDa fibronectin receptor of E. histolytica, although a serum analysis by ELISA was negative for IgG antibodies against this parasite. A specific E. histolytica 128 bp rRNA gene was identified by PCR in biopsy tissue. The final diagnosis was cerebral amoebiasis. The patient underwent neurosurgery to eliminate amoebic abscesses and was then given a regimen of metronidazole, ceftriaxone and dexamethasone for 4 weeks after the neurosurgery. However, a rapid decline in her condition led to death. CONCLUSIONS: The present case of an individual with a rare form of cerebral amoebiasis highlights the importance of performing immunofluorescence, NMRI and PCR if a patient has brain abscess and a poorly defined diagnosis. Moreover, the administration of corticosteroids to such patients can often lead to a rapid decline in their condition.


Asunto(s)
Absceso Encefálico/diagnóstico , Absceso Encefálico/parasitología , Infecciones Parasitarias del Sistema Nervioso Central/diagnóstico , Entamebiasis/diagnóstico , Anciano , Animales , Absceso Encefálico/tratamiento farmacológico , Absceso Encefálico/cirugía , Ceftriaxona/administración & dosificación , Infecciones Parasitarias del Sistema Nervioso Central/tratamiento farmacológico , Infecciones Parasitarias del Sistema Nervioso Central/patología , Infecciones Parasitarias del Sistema Nervioso Central/cirugía , Terapia Combinada , ADN Protozoario/análisis , Dexametasona/administración & dosificación , Quimioterapia Combinada , Entamoeba histolytica/genética , Entamoeba histolytica/inmunología , Entamoeba histolytica/aislamiento & purificación , Entamebiasis/tratamiento farmacológico , Entamebiasis/patología , Entamebiasis/cirugía , Resultado Fatal , Femenino , Humanos , Metronidazol/administración & dosificación , Procedimientos Neuroquirúrgicos , Pruebas Serológicas
2.
Semin Neurol ; 39(3): 358-368, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-31378871

RESUMEN

Parasitic infections of the central nervous system are much more common than suspected, although most infections are asymptomatic. For example, parasites like the ubiquitous protozoa Toxoplasma gondii or the nematode larvae Toxocara canis infect significant proportions of the human population. Other parasitic infections such as malaria and neurocysticercosis are widespread in developing countries and become major causes of neurological morbidity in these regions as well in immigrants and travelers. This article reviews parasitic pathogens causing neurological morbidity and mortality, including an extensive list of less common parasitic infections of the human nervous system.


Asunto(s)
Antiparasitarios/uso terapéutico , Infecciones Parasitarias del Sistema Nervioso Central/diagnóstico , Infecciones Parasitarias del Sistema Nervioso Central/tratamiento farmacológico , Humanos , Malaria Cerebral/diagnóstico , Malaria Cerebral/tratamiento farmacológico , Neurocisticercosis/diagnóstico , Neurocisticercosis/tratamiento farmacológico , Toxoplasmosis Cerebral/diagnóstico , Toxoplasmosis Cerebral/tratamiento farmacológico
3.
PLoS Negl Trop Dis ; 12(10): e0006918, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30346956

RESUMEN

BACKGROUND: Sparganosis is a parasitic infection caused by the plerocercoid larvae of Spirometra mansoni in East and Southeast Asia. The plerocercoid larvae sometimes invade the encephalon, resulting in severe cerebral sparganosis. Surgical removal of the larvae is considered a standard therapy for cerebral sparganosis. In contrast, the efficacy and safety of long-term, high-dose praziquantel treatment for cerebral sparganosis have not been explored. METHODOLOGY/PRINCIPAL FINDINGS: In this multicenter retrospective study, we assessed the records of 96 patients with cerebral sparganosis who consulted at three medical centers from 2013 to 2017. Forty-two patients underwent surgical lesion removal, and the other 54 patients received long-term, high-dose praziquantel (50 mg/kg/day for 10 days, repeated at monthly intervals). The primary outcome was the complete disappearance of active lesions on cerebral magnetic resonance imaging. The secondary outcomes included the modified Rankin scale score at 90 days, incidence of seizure, eosinophil count, and serological Spirometra. mansoni antibody titer. The efficacy of praziquantel treatment was similar to that of surgical lesion removal for cerebral sparganosis with respect to both the primary outcome and secondary outcomes. Although binary logistic regression models also supported the primary outcome after adjustment for age, sex, lesion location, and loss to follow-up, some unavoidable confounders might have biased the statistical power. No significant clinical complications or laboratory side effects occurred in the praziquantel group with the exception of a relatively benign allergic reaction. CONCLUSIONS/SIGNIFICANCE: In this small-sample, nonrandomized, retrospective exploratory study, some patients with cerebral sparganosis were responsive to long-term, high-dose praziquantel with an efficacy similar to that of surgical lesion removal. These findings increase the treatment flexibility for this serious infection.


Asunto(s)
Antihelmínticos/uso terapéutico , Infecciones Parasitarias del Sistema Nervioso Central/tratamiento farmacológico , Infecciones Parasitarias del Sistema Nervioso Central/cirugía , Procedimientos Neuroquirúrgicos/métodos , Praziquantel/uso terapéutico , Esparganosis/tratamiento farmacológico , Esparganosis/cirugía , Adolescente , Adulto , Asia Sudoriental , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
4.
Neurocirugia (Astur) ; 28(4): 207-210, 2017.
Artículo en Español | MEDLINE | ID: mdl-27986389

RESUMEN

Hydatid disease is an accidental parasitosis, with brain location being rare. The case is reported of a 33year-old male, with no history of note, who was admitted to hospital with intracranial hypertension syndrome and right hemiparesis. Computed tomography showed a cystic lesion in the left frontal-parietal lobule. Surgery was performed by complete excision of the lesion, with a good outcome. Hydatid disease is a rare condition in the brain. Clinical suspicion is important for an early diagnosis. A review is presented on the pathogenesis, diagnosis and treatment of cerebral hydatid disease.


Asunto(s)
Infecciones Parasitarias del Sistema Nervioso Central/diagnóstico por imagen , Equinococosis/diagnóstico por imagen , Adulto , Albendazol/uso terapéutico , Crianza de Animales Domésticos , Antihelmínticos/uso terapéutico , Infecciones Parasitarias del Sistema Nervioso Central/complicaciones , Infecciones Parasitarias del Sistema Nervioso Central/tratamiento farmacológico , Infecciones Parasitarias del Sistema Nervioso Central/cirugía , Terapia Combinada , Craneotomía , Equinococosis/complicaciones , Equinococosis/tratamiento farmacológico , Equinococosis/cirugía , Lóbulo Frontal/diagnóstico por imagen , Lóbulo Frontal/parasitología , Humanos , Masculino , Náusea/etiología , Exposición Profesional , Paresia/etiología , Lóbulo Parietal/diagnóstico por imagen , Lóbulo Parietal/parasitología , Perú , Tomografía Computarizada por Rayos X , Vómitos/etiología
5.
J Neurosurg Pediatr ; 15(1): 101-6, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25380173

RESUMEN

OBJECT: The authors retrospectively analyzed the clinical characteristics, existing problems, and treatment experiences in recently diagnosed cerebral paragonimiasis (CP) cases and sought to raise awareness of CP and to supply reference data for early diagnosis and treatment. METHODS: Twenty-seven patients (22 male and 5 female; median age 20.3 years, range 4-47 years) with CP were diagnosed between September 2008 and September 2013. These diagnoses were confirmed by IgG enzyme-linked immunosorbent assays. Follow-up was performed in 24 cases for a period of 6-56 months. RESULTS: Cerebral paragonimiasis accounted for 21.6% of paragonimiasis cases (27 of 125). The average duration from onset to praziquantel treatment was 69 days. All patients resided in rural areas. Twenty patients had positive lung results, which included visible lung lesions in 14 cases. The lesions were surgically removed in 8 of these cases. Twenty-four patients had high eosinophil counts (≥ 0.08 × 10(9)/L), and eosinophilic meningitis was noted in 17 cases. The rate of misdiagnosis and missed diagnosis was 30.4%. Most symptoms were markedly improved after treatment, but mild movement disorders combined with impaired memory and personality changes remained in a small number of patients. CONCLUSIONS: Clinicians should be alert to the possibility of CP in young patients (4-16 years) with the primary symptoms of epilepsy and hemorrhage. Early diagnosis and timely treatment can reduce the need for surgery and further impairments to brain function. Liquid-based cytological examination of CSF and peripheral blood eosinophil counts can aid in differentiating CP from similar lesions.


Asunto(s)
Infecciones Parasitarias del Sistema Nervioso Central/diagnóstico , Epilepsia/parasitología , Enfermedades Pulmonares Parasitarias/diagnóstico , Paragonimiasis/diagnóstico , Adolescente , Adulto , Antihelmínticos/uso terapéutico , Infecciones Parasitarias del Sistema Nervioso Central/complicaciones , Infecciones Parasitarias del Sistema Nervioso Central/tratamiento farmacológico , Infecciones Parasitarias del Sistema Nervioso Central/patología , Niño , Preescolar , China , Diagnóstico Diferencial , Diagnóstico Precoz , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Enfermedades Pulmonares Parasitarias/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Paragonimiasis/complicaciones , Paragonimiasis/tratamiento farmacológico , Paragonimiasis/patología , Fotomicrografía , Praziquantel/uso terapéutico , Estudios Retrospectivos , Población Rural , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Adulto Joven
6.
Mem. Inst. Oswaldo Cruz ; 109(4): 399-407, 03/07/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-716315

RESUMEN

Eosinophilic meningitis (EoM) is an acute disease that affects the central nervous system. It is primarily caused by infection with the nematode Angiostrongylus cantonensis. This infection was previously restricted to certain Asian countries and the Pacific Islands, but it was first reported in Brazil in 2007. Since then, intermediate and definitive hosts infected with A. cantonensis have been identified within the urban areas of many states in Brazil, including those in the northern, northeastern, southeastern and southern regions. The goals of this review are to draw the attention of the medical community and health centres to the emergence of EoM in Brazil, to compile information about several aspects of the human infection and mode of transmission and to provide a short protocol of procedures for the diagnosis of this disease.


Asunto(s)
Animales , Humanos , Infecciones Parasitarias del Sistema Nervioso Central , Eosinofilia , Meningitis , Infecciones por Strongylida , Angiostrongylus cantonensis , Brasil/epidemiología , Enfermedades Transmisibles Emergentes , Infecciones Parasitarias del Sistema Nervioso Central/diagnóstico , Infecciones Parasitarias del Sistema Nervioso Central/tratamiento farmacológico , Infecciones Parasitarias del Sistema Nervioso Central/epidemiología , Eosinofilia/diagnóstico , Eosinofilia/tratamiento farmacológico , Eosinofilia/epidemiología , Eosinofilia/parasitología , Meningitis/diagnóstico , Meningitis/tratamiento farmacológico , Meningitis/epidemiología , Meningitis/parasitología , Caracoles/parasitología , Infecciones por Strongylida/diagnóstico , Infecciones por Strongylida/tratamiento farmacológico , Infecciones por Strongylida/epidemiología
7.
Handb Clin Neurol ; 112: 1139-52, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23622322

RESUMEN

Parasites infect the central nervous system of children, particularly in resource-poor areas and tropical countries. However, these infections are increasingly seen in the West with the increase in children travelling to these areas and immigrant populations. These conditions are important in the differential diagnosis of common neurological syndromes. Falciparum malaria is a common cause of seizures and coma in endemic areas. Neurocysticercosis is a common cause of acquired epilepsy in some areas. Schistosomiasis is an important cause of spinal cord disease. Toxocara is ubiquitous and may cause encephalitis and retinal changes, and may be associated with epilepsy. Other parasitic conditions tend to be localized to specific regions of the world. Parasitic diseases are often associated with eosinophilia, and some cause an eosinophilic meningoencephalitis, although there are many nonparasitic causes of this syndrome. Most parasitic conditions can be treated, but in some diseases it is unclear whether the treatment influences outcome.


Asunto(s)
Infecciones Parasitarias del Sistema Nervioso Central/diagnóstico , Malaria/diagnóstico , Neurocisticercosis/diagnóstico , Convulsiones/diagnóstico , Infecciones Parasitarias del Sistema Nervioso Central/tratamiento farmacológico , Niño , Diagnóstico Diferencial , Humanos , Malaria/tratamiento farmacológico , Neurocisticercosis/tratamiento farmacológico , Convulsiones/parasitología
8.
Clin Microbiol Rev ; 22(2): 322-48, Table of Contents, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19366917

RESUMEN

Eosinophilic meningoencephalitis is caused by a variety of helminthic infections. These worm-specific infections are named after the causative worm genera, the most common being angiostrongyliasis, gnathostomiasis, toxocariasis, cysticercosis, schistosomiasis, baylisascariasis, and paragonimiasis. Worm parasites enter an organism through ingestion of contaminated water or an intermediate host and can eventually affect the central nervous system (CNS). These infections are potentially serious events leading to sequelae or death, and diagnosis depends on currently limited molecular methods. Identification of parasites in fluids and tissues is rarely possible, while images and clinical examinations do not lead to a definitive diagnosis. Treatment usually requires the concomitant administration of corticoids and anthelminthic drugs, yet new compounds and their extensive and detailed clinical evaluation are much needed. Eosinophilia in fluids may be detected in other infectious and noninfectious conditions, such as neoplastic disease, drug use, and prosthesis reactions. Thus, distinctive identification of eosinophils in fluids is a necessary component in the etiologic diagnosis of CNS infections.


Asunto(s)
Infecciones Parasitarias del Sistema Nervioso Central , Eosinofilia , Helmintiasis , Meningoencefalitis , Animales , Infecciones Parasitarias del Sistema Nervioso Central/diagnóstico , Infecciones Parasitarias del Sistema Nervioso Central/tratamiento farmacológico , Infecciones Parasitarias del Sistema Nervioso Central/epidemiología , Infecciones Parasitarias del Sistema Nervioso Central/parasitología , Eosinofilia/diagnóstico , Eosinofilia/tratamiento farmacológico , Eosinofilia/epidemiología , Eosinofilia/parasitología , Helmintiasis/diagnóstico , Helmintiasis/tratamiento farmacológico , Helmintiasis/epidemiología , Helmintiasis/parasitología , Humanos , Meningoencefalitis/diagnóstico , Meningoencefalitis/tratamiento farmacológico , Meningoencefalitis/epidemiología , Meningoencefalitis/parasitología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA